Inflammatix_Inc Profile Banner
Inflammatix Profile
Inflammatix

@Inflammatix_Inc

Followers
1K
Following
287
Media
260
Statuses
664

Our expertise in reading a patient’s immune response led to TriVerity™, an IVD test for patients with suspected acute infection or sepsis.

San Francisco Bay Area
Joined February 2017
Don't wanna be here? Send us removal request.
@Inflammatix_Inc
Inflammatix
2 months
The leadership behind #TeamInflammatix is expanding in new and exciting ways to meet the demand of the #TriVerity Test System launch! Today, we are thrilled to announce Martín Vazquez as our new Chief Operating Officer🎉. See press release:
Tweet media one
0
0
1
@Inflammatix_Inc
Inflammatix
2 months
Proud to see our very own Shailee Rasania recognized as a distinguished speaker at the US Medical Device & Diagnostic Post-Market Surveillance Conference this week! #meddevice #qra #clinicaloperations #leadership #medtech
Tweet media one
0
0
1
@Inflammatix_Inc
Inflammatix
3 months
As #LabWeek2025 wraps, we’re celebrating Stephen Gombos, Director of Lab Services at Licking Memorial. From diagnosing acute infections to mentoring future leaders, Stephen's impact is felt across the lab and beyond. Thank you for all you do!. #TheLabIsEverything #PatientCare
Tweet media one
0
1
1
@Inflammatix_Inc
Inflammatix
3 months
We had a great time connecting with microbiology leaders at #ESCMIDGlobal! Our Senior Director of Medical Affairs Natalie Whitfield presented the latest data on the science and unique capability behind #TriVerity. Thank you to @ESCMID for hosting such a connective event!
Tweet media one
0
0
0
@Inflammatix_Inc
Inflammatix
3 months
It's #LabWeek2025! So pleased to recognize the incredible laboratorians whose passion for making a difference in the lives of patients is clear from every interaction we have. Please give the lab folks in your life some extra appreciation this week — they deserve it!
Tweet media one
0
0
1
@Inflammatix_Inc
Inflammatix
4 months
Our rockstar Senior Director of Medical Affairs Natalie Whitfield is heading to @ESCMID to represent #TeamInflammatix and educate peers about #TriVerity! Stop by Hall 11 at 11am on April 14th to hear Natalie present new data about our work.
Tweet media one
0
0
2
@Inflammatix_Inc
Inflammatix
4 months
That's a wrap on #AAEM2025! Our CEO @TimSweeney83 and CMO Dr. Sam Ajizian presented our latest advancements in host-response diagnostics, highlighting our commitment to transforming acute infection and sepsis care. Thanks @aaeminfo for facilitating such a great event!
Tweet media one
Tweet media two
Tweet media three
0
1
3
@Inflammatix_Inc
Inflammatix
4 months
RT @Inflammatix_Inc: Join us 4/16 and 4/17 for an in-depth webinar on the TriVerity™ Test System and the impact of rapid sepsis detection o….
0
1
0
@Inflammatix_Inc
Inflammatix
4 months
Join us 4/16 and 4/17 for an in-depth webinar on the TriVerity™ Test System and the impact of rapid sepsis detection on both hospitals and patients, led by CMO Sam Ajizian, M.D. Register here:.4/16: 4/17:
0
1
2
@Inflammatix_Inc
Inflammatix
4 months
We’re honored to announce that we have signed a contract with the @JPEOCBRND to help the U.S. military detect the presence and assess the severity of acute infections or sepsis under battlefield conditions. Read today’s announcement: #Sepsis #Diagnostics.
inflammatix.com
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) purchases TriVerity Test System to evaluate for use in the field Inflammatix receives an...
0
1
1
@Inflammatix_Inc
Inflammatix
4 months
8 years in the making, and the big moment is finally here! The first-ever commercial shipment of the #TriVerity test system (incl. TriVerity Cartridges + the Myrna Instrument) left our HQ & got delivered to our first customer! Thank you everyone who made this milestone possible!
Tweet media one
Tweet media two
Tweet media three
0
2
11
@Inflammatix_Inc
Inflammatix
5 months
Our Co-founder and Chief Scientist @purveshkhatri will join a panel tomorrow at @TriConference to discuss the power of host-response profiling, including how its ready for prime time now in its ability to improve patient care. See details:
Tweet media one
0
0
4
@Inflammatix_Inc
Inflammatix
5 months
This Patient Safety Awareness Week, we join @TheIHI to Move the Needle together by offering the healthcare community better tools to improve patient safety in patients suspected of acute infections and sepsis. #PatientSafety #ptsafety #sepsis
Tweet media one
0
0
4
@Inflammatix_Inc
Inflammatix
5 months
Sepsis treatment isn’t one-size-fits-all, as a study in @CritCareMed shows, treatment response varies widely across #sepsis patients. By leveraging gene expression, we can push precision medicine forward in critical care.
Tweet card summary image
journals.lww.com
to conflicting average treatment effects in prior RCTs. DESIGN: We randomly split study sites from the Australian Resuscitation of Sepsis Evaluation (ARISE) and Protocolized Care for Early Septic...
0
1
4
@Inflammatix_Inc
Inflammatix
5 months
Join us at the Critical Care Congress #SCCM2025 in Orlando, or virtually, for an oral presentation by @TimSweeney83 - go here to register
Tweet media one
0
1
3
@Inflammatix_Inc
Inflammatix
5 months
Thanks @QIAGEN for capturing our story, including video of our Co-Founder and CEO @TimSweeney83 discussing the use of TriVerity to effectively triage #sepsis in the ED. #PrecisionMedicine.
@QIAGEN
QIAGEN
5 months
Sepsis is a leading cause of hospital deaths. Physician & researcher Tim Sweeney saw this firsthand - patients waiting hours for test results while sepsis silently progressed. But what if we could detect the risk earlier by analyzing the immune system’s response? 👇.
0
0
1
@Inflammatix_Inc
Inflammatix
6 months
Our CEO and Co-Founder @TimSweeney83 comments on the potential of AI to reshape healthcare in @ScienceNews - see section "AI could calculate health risks from patient data"
Tweet card summary image
sciencenews.org
AI has the potential to make health care more effective, equitable and humane. Whether the tech delivers on these promises remains to be seen.
0
1
6
@Inflammatix_Inc
Inflammatix
6 months
Thanks to Stanford Medicine for interviewing @purveshkhatri to tell the TriVerity story following its recent FDA clearance, which started in Dr. Khatri's lab with @TimSweeney83 a decade ago. Their pioneering work led them and @jmeabr to cofound Inflammatix in 2016. Great read!.
@StanfordMed
Stanford Medicine
6 months
A new sepsis test developed at Stanford Medicine uses machine learning and publicly available medical datasets from around the world to speed up life-saving diagnoses.
0
4
9
@Inflammatix_Inc
Inflammatix
6 months
Surviving sepsis is just the beginning. This Sepsis Survivor Week, we honor survivors and the unseen struggles they face after leaving the hospital. #SepsisSurvivor @SepsisAlliance
Tweet media one
0
0
3
@Inflammatix_Inc
Inflammatix
6 months
RT @Inflammatix_Inc: TriVerity™ has received FDA clearance! Our innovative diagnostic uses AI/ML + host-response to quickly and accurately….
0
8
0